Evidence map›Paper›PMID 20944228›Full record

ArticleActa crystallographica. Section F, Structural biology and crystallization communications2010

The structure of Haemophilus influenzae prephenate dehydrogenase suggests unique features of bifunctional TyrA enzymes.

Hsiu Ju Chiu, Polat Abdubek, Tamara Astakhova, Herbert L Axelrod, Dennis Carlton, Thomas Clayton, Debanu Das, Marc C Deller, Lian Duan, Julie Feuerhelm and 29 more

Open access · hybridAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology and crystallization communications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 7 institutions in 1 country.

Hsiu Ju ChiuStanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA, USA.
Polat Abdubek
Tamara Astakhova
Herbert L Axelrod
Dennis Carlton
Thomas Clayton
Debanu Das
Marc C Deller
Lian Duan
Julie Feuerhelm
Joanna C Grant
Anna Grzechnik
Gye Won Han
Lukasz Jaroszewski
Kevin K Jin
Heath E Klock
Mark W Knuth
Piotr Kozbial
S Sri Krishna
Abhinav Kumar
David Marciano
Daniel McMullan
Mitchell D Miller
Andrew T Morse
Edward Nigoghossian
Linda Okach
Ron Reyes
Henry J Tien
Christine B Trame
Henry van den Bedem
Dana Weekes
Qingping Xu
Keith O Hodgson
John Wooley
Marc André Elsliger
Ashley M Deacon
Adam Godzik
Scott A Lesley
Ian A Wilson
Joint Center for Structural Genomics · USGenomics Institute of the Novartis Research Foundation · USSLAC National Accelerator Laboratory · USStanford Synchrotron Radiation Lightsource · USUniversity of California, San Diego · USScripps Research Institute · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Technology Evaluation CoreU54GM074898 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI STEVENS, RAYMOND C · 2005 to 2009
$50.6M
NIGMS NIH HHS U54 GM074898
6 · The paper itself

Abstract

Chorismate mutase/prephenate dehydrogenase from Haemophilus influenzae Rd KW20 is a bifunctional enzyme that catalyzes the rearrangement of chorismate to prephenate and the NAD(P)(+)-dependent oxidative decarboxylation of prephenate to 4-hydroxyphenylpyruvate in tyrosine biosynthesis. The crystal structure of the prephenate dehydrogenase component (HinfPDH) of the TyrA protein from H. influenzae Rd KW20 in complex with the inhibitor tyrosine and cofactor NAD(+) has been determined to 2.0 Å resolution. HinfPDH is a dimeric enzyme, with each monomer consisting of an N-terminal α/β dinucleotide-binding domain and a C-terminal α-helical dimerization domain. The structure reveals key active-site residues at the domain interface, including His200, Arg297 and Ser179 that are involved in catalysis and/or ligand binding and are highly conserved in TyrA proteins from all three kingdoms of life. Tyrosine is bound directly at the catalytic site, suggesting that it is a competitive inhibitor of HinfPDH. Comparisons with its structural homologues reveal important differences around the active site, including the absence of an α-β motif in HinfPDH that is present in other TyrA proteins, such as Synechocystis sp. arogenate dehydrogenase. Residues from this motif are involved in discrimination between NADP(+) and NAD(+). The loop between β5 and β6 in the N-terminal domain is much shorter in HinfPDH and an extra helix is present at the C-terminus. Furthermore, HinfPDH adopts a more closed conformation compared with TyrA proteins that do not have tyrosine bound. This conformational change brings the substrate, cofactor and active-site residues into close proximity for catalysis. An ionic network consisting of Arg297 (a key residue for tyrosine binding), a water molecule, Asp206 (from the loop between β5 and β6) and Arg365' (from the additional C-terminal helix of the adjacent monomer) is observed that might be involved in gating the active site.

Indexed as

Bacterial ProteinsCrystallography, X-RayHaemophilus influenzaeMultienzyme ComplexesPrephenate DehydrogenaseBacterial ProteinsMultienzyme ComplexesPrephenate DehydrogenaseTyrA protein, Bacteria

Identifiers

PMID20944228
PMCPMC2954222
OpenAlexW2162410670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.